Evolvere BioSciences
PrivateLast Round
Accelerator
Aug 23, 2024
Total Funding Raised
$500,000
Company Overview
Evolvere BioSciences operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was an Accelerator round in August 2024.
Evolvere BioSciences is a biotechnology company that develops a therapeutics platform to combat antimicrobial resistance by creating next-generation antibiotics using AI-powered computational models.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evolvere BioSciences Comparables
Compare Evolvere BioSciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glox Therapeutics | 78% | |
| A-Alpha Bio | 66% | |
| Ailurus Biotechnology | 66% |
For institutional investors. Book with your work email.
Evolvere BioSciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Evolvere BioSciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator |
Evolvere BioSciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evolvere BioSciences's valuation, stock price, and market status.
Is Evolvere BioSciences a public or private company?
Evolvere BioSciences is a private company.
What is the current stock price of Evolvere BioSciences?
Evolvere BioSciences is a private company, so its shares have no public market price. Caplight tracks Evolvere BioSciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evolvere BioSciences worth (valuation)?
Valuation information for Evolvere BioSciences is not publicly available.
Can I buy Evolvere BioSciences stock?
Evolvere BioSciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evolvere BioSciences's last funding round?
Evolvere BioSciences's most recent funding round was Accelerator on August 23, 2024.
Who are the main investors in Evolvere BioSciences?
Key investors in Evolvere BioSciences include Y Combinator.
Will Evolvere BioSciences IPO soon?
No public IPO plans have been announced for Evolvere BioSciences.
How can I track Evolvere BioSciences secondary market activity?
Caplight tracks bids, offers, and trades in Evolvere BioSciences's shares on secondary markets.